Cargando…

Disease Activity and Bone Mineral Density of MCP Joints in Patients with Rheumatoid and Psoriatic Arthritis: Is There a Correlation?—A Study in Patients Treated with Methotrexate and an Anti-TNFα Agent

Background. Bone damage in rheumatoid arthritis (RA) and in psoriatic arthritis (PsA) includes an accelerated bone mineral density (BMD) reduction. The objective was to evaluate BMD variations of the metacarpophalangeal joints (MCPs) in patients starting treatment with methotrexate (MTX) or etanerce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertoldi, Ilaria, Filippou, Georgios, Scirè, Carlo Alberto, Picerno, Valentina, di Sabatino, Valentina, Adinolfi, Antonella, Pierguidi, Serena, Galeazzi, Mauro, Frediani, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871921/ https://www.ncbi.nlm.nih.gov/pubmed/24381766 http://dx.doi.org/10.1155/2013/708323

Ejemplares similares

Do Not Hallow until You Are out of the Wood! Ultrasonographic Detection of CPP Crystal Deposits in Menisci: Facts and Pitfalls
por: Filippou, Georgios, et al.
Publicado: (2013)

Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice
por: Fabbroni, Marta, et al.
Publicado: (2014)

Cutaneous Eruption after SARS-CoV-2 Vaccine in Psoriatic Patient Treated with Methotrexate
por: Serena, Lembo, et al.
Publicado: (2022)

Corticosteroid injection treatment for dactylitis in psoriatic arthritis
por: Carriero, Antonio, et al.
Publicado: (2021)

TNF-α Activating Osteoclasts in Patients with Psoriatic Arthritis Enhances the Recruitment of Osteoclast Precursors: A Plausible Role of WNT5A-MCP-1 in Osteoclast Engagement in Psoriatic Arthritis
por: Lin, Shang-Hung, et al.
Publicado: (2022)

Non-adherence and discontinuation rate for oral and parenteral methotrexate: A retrospective-cohort study in 8,952 patients with psoriatic arthritis
por: Generali, Elena, et al.
Publicado: (2021)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

Intramuscular Clodronate in Long-Term Treatment of Symptomatic Knee Osteoarthritis: A Randomized Controlled Study
por: Frediani, Bruno, et al.
Publicado: (2020)

Effectiveness, Safety and Tolerance of Methotrexate in Vietnamese Psoriatic Arthritis Patients
por: Thi, Van Bui, et al.
Publicado: (2019)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Psoriatic Arthritis with Acral Lentiginous Melanoma: Role for Methotrexate?
por: Rahima, S, et al.
Publicado: (2013)

Methotrexate use and NAD(+)/NADH metabolism in psoriatic keratinocytes
por: Liszewska, Agata, et al.
Publicado: (2020)

Is there still a place for methotrexate in severe psoriatic arthritis?
por: Felten, Renaud, et al.
Publicado: (2022)

Severe, Recurrent Crusted Scabies in a Psoriatic on Methotrexate
por: Khurana, Ananta, et al.
Publicado: (2022)

Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
por: Rattanakaemakorn, Ploysyne, et al.
Publicado: (2021)

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study
por: D’Angelo, Salvatore, et al.
Publicado: (2022)

Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-α
por: Cordiali-Fei, Paola, et al.
Publicado: (2006)

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
por: Kingsley, Gabrielle H., et al.
Publicado: (2012)

Psoriatic flare after the concomitant administration of L-methylfolate and methotrexate
por: Nazarian, Roya S., et al.
Publicado: (2016)

Sustained remission with methotrexate monotherapy after 22-week induction treatment with TNF-alpha inhibitor and methotrexate in early psoriatic arthritis: an open-label extension of a randomized placebo-controlled trial
por: de Jong, Henriëtte M. Y., et al.
Publicado: (2019)

The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients – preliminary report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2018)

Impact of rheumatoid arthritis and methotrexate on pregnancy outcomes: retrospective cohort study of the Italian Society for Rheumatology
por: Zanetti, Anna, et al.
Publicado: (2022)

Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study
por: Al Khayyat, Suhel Gabriele, et al.
Publicado: (2022)

Infantile perianal pyramidal protrusion: a case report with dermoscopy and ultrasound findings
por: Lamberti, Arianna, et al.
Publicado: (2015)

Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity
por: Maiti, Debarati, et al.
Publicado: (2023)

From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis
por: Silvagni, Ettore, et al.
Publicado: (2021)

Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux
por: Pastore, Valentina, et al.
Publicado: (2017)

16. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017)

10. Reactivation of hepatitis B virus in a patient with psoriatic arthritis treated with methotrexate
por: Mudawi, Tareg, et al.
Publicado: (2017)

Unusual Cutaneous Reaction at Site of Methotrexate Injection in Two Patients with Psoriasis and Psoriatic Arthritis
por: SADOGHI, Birgit, et al.
Publicado: (2021)

Treating psoriatic arthritis: how effective are TNF antagonists?
por: Gottlieb, Alice B, et al.
Publicado: (2004)

Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
por: Pirowska, Magdalena M., et al.
Publicado: (2015)

TNF-induced IL-8 and MCP-1 production in the eosinophilic cell line, EOL-1
por: Goldstein, L. A., et al.
Publicado: (1996)

Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer
por: Sáenz-López, Pablo, et al.
Publicado: (2008)

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis
por: Liu, Yong, et al.
Publicado: (2014)

Low-dose methotrexate-induced ulcerated psoriatic plaques: A rare case
por: Hsu, Ming-Chun, et al.
Publicado: (2015)

Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study
por: Dehpouri, Tannaz, et al.
Publicado: (2019)

Methotrexate Reduced TNF Bioactivity in Rheumatoid Arthritis Patients Treated with Infliximab
por: Dénarié, Delphine, et al.
Publicado: (2017)

Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
por: Wang, Qiaolei, et al.
Publicado: (2020)

Clinical and ultrasonographic predictors for achieving minimal disease activity in patients with psoriatic arthritis: the UPSTREAM (Ultrasound in PSoriatic arthritis TREAtMent) prospective observational study protocol
por: Canzoni, Marco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7hheh583bs77m07dvg19fu7rt6